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Peter MA CalverleyDoctors are not short of advice about how to manage
their patients. In the case of COPD (Chronic Obstruct-
ive Pulmonary Disease) there are a wealth of guidelines,
strategies and position papers synthesising an increasing
body of data from observational studies and clinical tri-
als into schemes that should help the doctor care for
their COPD patients more effectively. In recent years
particular attention has been paid to the views of the
joint ERS/ATS COPD guidelines [1] and the regularly
updated recommendations of the Global initiative for
chronic Obstructive Lung Disease (GOLD) [2]. Now a
new Italian document has been developed representing
the combined efforts of three key Italian respiratory so-
cieties AIMAR, AIPO, SIMeR and the society of General
Practice, SIMG, whose combined expertise covers almost
all those who offer care to the COPD patient. So what
does this new guidance tell us and does it add to what we
have heard already?
Appropriately this new document takes a very wide
view of the problems of COPD. It emphasises the need
for early accurate diagnosis supported when needed but
supplementary physiological investigations such as the
measurement of lung volumes and airway responsive-
ness. It points out the limitations of relying on a fixed
FEV1/FVC ratio of 70% or less to support the diagnosis
of COPD and suggest instead that the lower limit of nor-
mal (LLN) for this ratio is a more reliable guide. There
might have been a little more advice for the busy clin-
ician on the best way of accessing appropriate LLN data
and perhaps a little more caution on the usefulness of
bronchodilator testing in patient evaluation [3]. However
there are some excellent figures to guide diagnosis and
management as well as useful tabular summaries of what
tests should be undertaken by which clinicians and how
to approach smoking cessation.
The authors have avoided some of the controversy and
uncertainty surrounding the new GOLD severity assess-
ment scheme [4], instead focussing on patient sub-groups
that correspond to those seen in clinical practice and in
clinical trials. Their treatment recommendations are notCorrespondence: pmacal@liverpool.ac.uk
School of Ageing and Chronic Disease, University of Liverpool, Liverpool, UK
© 2014 Calverley; licensee BioMed Central Ltd
Commons Attribution License (http://creativec
reproduction in any medium, provided the or
Dedication waiver (http://creativecommons.or
unless otherwise stated.formally evidence based but closely follow those in guide-
lines where more extensive evidence evaluations have
been conducted [5]. The authors offer clear practical guid-
ance with support from selected but relevant literature ci-
tations which help the clinician understand why particular
treatment choices have been made. There is an appropri-
ate and pragmatic section emphasising the value of pul-
monary rehabilitation together with a particularly helpful
review of the role of telemedicine in COPD care, a topic
scarcely touched on in other guidelines.
This new approach to COPD care is needed in Italy now.
As the authors point out, COPD remains a major health
problem despite much good work to increase smoking ces-
sation rates and improve air quality. International guide-
lines offer an overview of COPD care in all settings but
there is still a need to develop management strategies
which work locally and reflect the needs and perceptions
of local physicians and patients. This new initiative has
achieved both of these goals admirably.
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